Superinvestor Tracker
← All Investors

GAIN THERAPEUTICS INC

GANX

Holders

1

Combined Value

$1.92M

Combined Shares

588,410

Current Price

$1.68

52W High

$4.34

vs 52W High

−61.3%

Investor Activity Chart

Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.

Held By

Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of
David Einhorn - Greenlight Capital$1.92M0.09%~$4.03−58.3%BUY Q3 2023Q4 2023

Recent Activity

Latest position changes by tracked investors. Prices are estimates implied from 13F filings.

QuarterInvestorActionEst. ValueEst. Price
Q1 2026Jim Simons - Renaissance TechnologiesSOLD OUT−$56.0K~$3.22
Q4 2025Jim Simons - Renaissance TechnologiesSELL−$350.0K~$3.22
Q3 2025Jim Simons - Renaissance TechnologiesBUY+$56.8K~$1.77
Q2 2025Jim Simons - Renaissance TechnologiesNEW BUY+$169.2K~$1.80
Q4 2024Jim Simons - Renaissance TechnologiesSOLD OUT−$94.8K~$1.78
Q3 2024Jim Simons - Renaissance TechnologiesSELL−$116.5K~$1.78
Q2 2024Jim Simons - Renaissance TechnologiesNEW BUY+$151.9K~$1.28
Q3 2023David Einhorn - Greenlight CapitalBUY+$137.3K~$3.28
Q1 2022David Einhorn - Greenlight CapitalNEW BUY+$2.24M~$4.09

Ownership History

Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q4 2025117,400-86.2%$56.0K$3.22
Q3 20251126,100+34.1%$223.2K$1.77
Q2 2025194,000+76.5%$169.2K$1.80
Q3 2024153,264-55.1%$94.8K$1.78
Q2 20241118,700-79.8%$151.9K$1.28
Q4 20231588,410UNCH$1.92M$3.26
Q3 20231588,410+7.7%$1.93M$3.28
Q2 20231546,560$2.45M$4.48